Clinical Report: HHS Secretary Kennedy Announces Conclusion of COVID-19 EUA Declarations

Overview

The HHS has announced the termination of COVID-19 Emergency Use Authorization declarations for drugs, biological products, and medical devices, effective after specified notice periods.

Background

The COVID-19 Emergency Use Authorization (EUA) declarations were initially established to facilitate rapid access to medical products during the pandemic. As the availability of FDA-approved products has increased and reliance on EUA products has decreased, the need for these emergency authorities has diminished.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

• The COVID-19 EUA declarations were first issued in 2020 to enable rapid access to medical products.
• Secretary Robert F. Kennedy, Jr. has signed determinations to terminate these declarations, stating that the circumstances justifying them no longer exist.
• The termination for drugs and biological products will take effect 12 months after the determination, while medical devices will terminate 180 days later.
• HHS will publish notices of the terminations in the Federal Register and notify Congress as required by law.
• Advance notice periods are intended to allow an orderly transition for manufacturers and healthcare providers.

Clinical Implications

Manufacturers and healthcare providers should prepare for the transition away from products authorized solely under the COVID-19 EUA declarations.

Conclusion

The conclusion of the COVID-19 EUA declarations marks a transition to standard regulatory practices for medical products.

Related Resources & Content

1. HHS Secretary Kennedy Signs COVID-19 Emergency Use Authorization Declaration Terminations | HHS.gov, 2026 -- HHS Successfully Concludes COVID-19 EUA Declarations
2. ADA News — Federal COVID-19 emergency declarations set to expire May 11
3. ADA News — CDC releases new guidance on broader masking in health care settings
4. ada news — RFK Jr. confirmed as HHS secretary
5. United States Department of Health and Human Services — HHS Successfully Concludes Hantavirus Response Effort; Monitoring Ends with No Positive U.S. Case
6. Federal COVID-19 emergency declarations set to expire May 11
7. CDC releases new guidance on broader masking in health care settings
8. RFK Jr. confirmed as HHS secretary
9. HHS Secretary Kennedy Signs COVID-19 Emergency Use Authorization Declaration Terminations | HHS.gov
10. COVID-19 Treatment Clinical Care for Outpatients | Covid | CDC
11. Nirmatrelvir/Ritonavir Efficacy in Immunocompetent Patients with Confirmed Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2: An Updated Systematic Review and Meta-analysis - PubMed